In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
For individuals researching BPC-157 for weight loss, the most realistic expectation is that it may help support the healthy habits that contribute to weight loss rather than acting as a standalone fat-loss solution
For the bigger picture, read how supervised peptide therapy at Perfect B in Doral is structured and how it supports safe, monitored use of peptides
Do not freeze after reconstitution
For patients in South Florida dealing with chronic UV and heat-related oxidative load year-round, this mechanism is particularly relevant to what we see in our Doral patient population